Company Intelligence

Persist AI

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.

In this profile

Quick Facts

  • Founded 2023
  • Headquarters Sacramento, United States
  • Country United States
  • Industry AI in Healthcare
  • Company Type Growth
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.

Why It Matters

Developing long-lasting drug formulations 50% faster

Recent Developments

  1. 2023 Company founded

    Persist AI was founded in 2023 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe